Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

European Study of Cerebral Aspergillosis Treated With Isavuconazole

NCT04486885 is registered in ClinicalTrials.gov with Imagine Institute as lead sponsor.

NCT NCT04486885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04486885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
European Study of Cerebral Aspergillosis Treated With Isavuconazole
Lead sponsor
Imagine Institute
Phase
Observational
Overall status
Completed
Start date
August 1, 2021
Completion date
March 1, 2023
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral aspergillosis, invasive aspergillosis